Bioventix PLC
BVXP.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £6,384 | £6,732 | £6,931 | £6,675 |
| % Growth | -5.2% | -2.9% | 3.8% | – |
| Cost of Goods Sold | £473 | £818 | £528 | £453 |
| Gross Profit | £5,910 | £5,914 | £6,403 | £6,222 |
| % Margin | 92.6% | 87.8% | 92.4% | 93.2% |
| R&D Expenses | £0 | £160 | £986 | £13 |
| G&A Expenses | £0 | £1,068 | £963 | £1,032 |
| SG&A Expenses | £989 | £1,059 | £952 | £1,077 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £45 |
| Other Operating Expenses | £0 | -£160 | -£986 | -£14 |
| Operating Expenses | £989 | £1,059 | £952 | £1,076 |
| Operating Income | £4,921 | £4,855 | £5,452 | £5,146 |
| % Margin | 77.1% | 72.1% | 78.7% | 77.1% |
| Other Income/Exp. Net | -£9 | £31 | -£73 | £92 |
| Pre-Tax Income | £4,912 | £4,886 | £5,378 | £5,238 |
| Tax Expense | £1,100 | £1,114 | £1,305 | £1,215 |
| Net Income | £3,812 | £3,772 | £4,073 | £4,024 |
| % Margin | 59.7% | 56% | 58.8% | 60.3% |
| EPS | 0.73 | 0.72 | 0.78 | 0.77 |
| % Growth | 1.4% | -7.7% | 1.3% | – |
| EPS Diluted | 0.72 | 0.71 | 0.78 | 0.76 |
| Weighted Avg Shares Out | 5,222 | 5,220 | 5,220 | 5,297 |
| Weighted Avg Shares Out Dil | 5,289 | 5,297 | 5,220 | 5,297 |
| Supplemental Information | – | – | – | – |
| Interest Income | £85 | £107 | £110 | £92 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £39 | £54 | £55 | £58 |
| EBITDA | £4,951 | £4,940 | £5,404 | £5,217 |
| % Margin | 77.6% | 73.4% | 78% | 78.2% |